WebOct 5, 2014 · Cisplatin, cisplatinum, or cis-diamminedichloroplatinum (II), is a well-known chemotherapeutic drug. It has been used for treatment of numerous human cancers including bladder, head and neck, lung, ovarian, and testicular cancers. It is effective against various types of cancers, including carcinoma … WebMay 12, 2024 · Cisplatin is the first-line chemotherapeutic agent for the treatment of oral squamous cell carcinoma (OSCC). However, the intrinsic or acquired resistance against cisplatin remains a major...
Recognition and repair of DNA-cisplatin adducts - PubMed
WebAug 7, 2009 · Stable knockdown of Brg1 and Brm enhanced cellular sensitivity to cisplatin. Repair kinetics of cisplatin DNA adducts revealed that downregulation of Brg1 and Brm impeded the repair of both intrastrand adducts and interstrand crosslinks (ICLs). Cisplatin ICL-induced DNA double strand break repair was also decreased in Brg1 and Brm … Cisplatin interferes with DNA replication, which kills the fastest proliferating cells, which in theory are cancerous. Following administration, one chloride ion is slowly displaced by water to give the aquo complex cis-[PtCl(NH3)2(H2O)] , in a process termed aquation. Dissociation of the chloride is favored inside the cell because the intracellular chloride concentration is only 3–20% of the approxi… ttp without thrombocytopenia
Cipla seeks to dismiss RTP drugmaker
WebApr 11, 2024 · Credit Repair Services. SELECT. All Personal Finance. Best Budgeting Apps. ... Pluvicto, for advanced prostate cancer, as well as methotrexate, cisplatin and fluorouracil, common ... Web1 day ago · 1.Introduction. The term DNA damage repair refers to a biological process during which alterations in the structure of DNA are removed and the integrity of the genome is restored to prevent cells from experiencing neoplastic transformation [1], [2].Base excision repair (BER), nucleotide excision repair (NER), mismatch repair (MMR), and DNA … WebApr 14, 2024 · Abstract. The concept of “BRCAness” was first described in 2004 to define the situation in which a homologous recombination repair (HRR) defect in a tumor relates to and phenocopies BRCA1 or BRCA2 loss-of-function mutations. Soon after the discovery of synthetic lethality of PARP1/2 inhibitors in BRCA1- or BRCA2-deficient cells, McCabe … phoenix physiotherapie